Logo

Tm Extends Alliance With Luminex to Sell Dx Products On xMAP Platform

Mar 29, 2006

NEW YORK, March 29 (GenomeWeb News) - Tm Bioscience has extended for  multiple additional years an agreement with Luminex to sell DNA-based molecular diagnostics that operate on Luminex's xMAP platform, Tm said today.

 

All of Tm's genetic tests use its Tag-It Universal Array platform. Tm's assays, meantime, use Luminex's xMAP platform.

 

The original agreement between the two companies, launched in 2001, expired yesterday. The renegotiated deal incorporates "similar terms" to the original, including the ability for Tm to distribute such xMAP systems as the new LX200 instrument, Tm said.


Financial terms of the deal were not disclosed.

Breaking News
The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.